German Cancer Research Center Experts Call for Strict Ban on E-cigarette Ads on Social Media

Jun.03.2024
German Cancer Research Center Experts Call for Strict Ban on E-cigarette Ads on Social Media
German cancer researchers call for stricter e-cigarette ad bans on social media to protect youth health. The current ban is inadequate.

According to SWR on May 31, experts from the German Cancer Research Center (DKFZ) are calling for stricter regulations on e-cigarette advertising online to protect the health of young people.


Since 2022, Germany has banned tobacco advertising in public areas such as posters, bus stops, and movies suitable for teenagers. As of the beginning of this year (2024), e-cigarette advertising, including online, has also been added to the ban. However, experts suggest that there is a legal "gray area" when it comes to e-cigarette advertising on social platforms, especially on platforms like TikTok or Instagram.


Expert Katrin Schaller from the research center stated that despite some restrictions on e-cigarette advertising currently being in place, there are still some loopholes. For example, e-cigarette ads can still be found at point of sale locations such as newsstands, gas stations, and some grocery stores. Additionally, while advertising e-cigarettes online has been prohibited, it is still seen as potentially legal on social media platforms.


However, Jan Mücke of the German Federal Tobacco Industry New Product Association (BVTE) expressed doubt about this. He emphasized that the industry's advertising methods are already restricted, and e-cigarette advertisements have not been allowed on posters since the beginning of the year. Mücke believes that simply imposing further advertising bans will not further reduce Germany's smoking rate, and a more effective approach would be for the government to enforce existing regulations more effectively.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Q2 2025: E-cigarette Unit Posts $108M Operating Loss; Nicotine Pouch on! Grows 26.5%
Altria Q2 2025: E-cigarette Unit Posts $108M Operating Loss; Nicotine Pouch on! Grows 26.5%
Altria Group 2025 disclosed on July 30, 2025, Q2 net income of $6.102 billion, down 1.7% year-over-year, and adjusted diluted EPS of $1.44, up 8.3% year-over-year, while first-half net income of $11.361 billion was down 3.6% year-over-year, and adjusted diluted EPS of $2.67, up 7.2% year-over-year.
Jul.31 by 2FIRSTS.ai
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT reported H1 2025 revenue of £12.07 billion, down 2.2% due to FX, but up 1.8% at constant rates. Smoke-free products made up 18.2% of total revenue, with Velo sales rising 40.6%. BAT maintained its full-year outlook and raised its 2025 share buyback to £1.1 billion.
Jul.31 by 2FIRSTS.ai
The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
Consumer Association of Penang (CAP) urges Malaysian government to follow Singapore in treating e-cigarettes as a drug threat.
Aug.25 by 2FIRSTS.ai
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
Altria’s subsidiary NJOY has sued the U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS), alleging prolonged delays in ruling on its appeal for flavored disposable vapes. NJOY argues the products are identical to authorized versions and backed by scientific data and safeguards, yet the review has taken far beyond statutory limits, blocking lawful products while illicit ones flood the market.
Aug.24
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
A new study shows that flavored e-cigarettes, even without nicotine, can interfere with embryo implantation and placental development, increasing the risks of miscarriage and fetal growth restriction, underscoring their potential threat to pregnancy safety.
Sep.01 by 2FIRSTS.ai
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud
France has banned producing, importing, distributing, and consuming oral nicotine products (e.g., nicotine pouches, gum) without parliamentary debate or multi-stakeholder consultation. This has sparked strong opposition from firms like British American Tobacco France and Philip Morris France, which argue it contradicts EU discussions, deprives smokers of reduced-harm alternatives, and lacks scientific basis. However, anti-smoking group Alliance Contre le Tabac hails it as a "victory" for public
Sep.08